🔗 Permalink

Inventor profile of:

Sofia Barluenga

City:

Strasbourg

Country:

France

Published Applications:

Last publication date:

2019-11-28

Top Assignees for applications by Sofia Barluenga

The entities that hold a legal rights for patent applications filed by inventor Barluenga Sofia:

UNIVERSITE DE STRASBOURG 9 Strasbourg, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 4 PARIS, France
UNIVERSITE DE STRASBOURG 2 Strasbourg Cedex, France
LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 2 Paris Cedex, France
NEXGENIX PHARMACEUTICALS 1 New York, NY United States
Nexgenix Pharmaceuticals, LLC 1 New York, NY United States
University de Strasbourg 1 Strasbourg, France

Recent patent applications by Barluenga Sofia

Sofia Barluenga from Strasbourg, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-11-28

US20190359585A1

Chemistry; metallurgy

SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS

#2 | 2017-06-22

US20170174669A1

Chemistry; metallurgy

POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES

#3 | 2016-03-17

US20160075677A1

Chemistry; metallurgy

Synthesis of resorcylic acid lactones useful as therapeutic agents

#4 | 2015-12-31

US20150374680A1

Human necessities

POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES

#5 | 2014-07-17

US20140200161A1

Chemistry; metallurgy

METHOD OF PREPARING AN ADDUCT

#6 | 2013-02-28

US20130053434A1

Chemistry; metallurgy

IRREVERSIBLE INHIBITORS USEFUL FOR THE TREATMENT OF KINASE-RELATED PATHOLOGIES

#7 | 2012-05-10

US20120115751A1

Chemistry; metallurgy

Method of preparing an adduct

#8 | 2012-03-29

US20120077775A1

Chemistry; metallurgy

Macrocyclic compounds useful as inhibitors of kinases and HSP90

#9 | 2011-09-08

US20110217335A1

Chemistry; metallurgy

Synthesis of resorcylic acid lactones useful as therapeutic agents

#10 | 2011-08-04

US20110190237A1

Chemistry; metallurgy

Macrocyclic Prodrug Compounds Useful as Therapeutics

#11 | 2010-11-18

US20100292218A1

Human necessities

Treatment of neurofibromatosis with radicicol and its derivatives

#12 | 2010-09-16

US20100233279A1

Chemistry; metallurgy

Compositions and methods comprising analogues of radicicol A

#13 | 2008-06-19

US20080146545A1

Chemistry; metallurgy

Macrocyclic compounds useful as inhibitors of kinases and HSP90

InventorID:

116441 ⎘